As of 2024-12-11, the Fair Value of Kinnate Biopharma Inc (KNTE) is -11.94 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.65 USD, the upside of Kinnate Biopharma Inc is -550.59%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -11.97 | -35.76 | -89.76 | -116.27 | -112.65 | -73.28 |
| YoY growth | -56.88% | -198.75% | -151.01% | -29.53% | 3.11% | -86.61% |
| Market Cap (mil) | 125.00 |
| P/E | |
| Forward P/E |
| EPS | -2.39 |
| Avg earnings growth rate | -86.61% |
| TTM earnings | -112.65 |